Facebook Twitter RSS Feed
 - cholesterol

More than half of respondents chose to go against guideline recommendations for a hypothetical patient whose risk score made him a candidate for statin therapy in poll results published in the July 24 issue of the New England Journal of Medicine.

 - tablet

From phone and tablet apps that help providers review imaging data to functions that turn phones into cardiac monitors, mobile health – or mHealth – is one area where the tide of innovation is turning to develop better patient care. Can the FDA keep up with new mHealth apps to ensure they are safe and effective? 

 - Decision aids help inform prostate cancer screening

There are many benefits to shared decision-making with patients. Informed patients make better decisions and have more meaningful and frank health discussions with their physicians, but there are as many barriers to an open conversation and shared decision between doctor and patient as there are benefits.

 - anticoagulants

The journal BMJ took aim at the anticoagulant dabigatran and its manufacturer in a three-pronged package published online July 23 that catalogued the drug’s tumultuous pre-approval and post-approval journeys in the U.S. and Europe. Maker Boehringer Ingelheim called the stories unbalanced.

 - female doctor, young male patient

If followed, the cholesterol guidelines published in late 2013 will increase the timing and frequency of initiating statin therapy in men, according to an editorial published in the July 11 issue of the Journal of Men’s Health. The authors added that the guidelines overlooked erectile dysfunction as a risk factor for coronary artery disease.